|
|
|
|
|
|
by Gatsky
1257 days ago
|
|
|
Yes, tailored screening is one aspect. Prophylactic surgery is another option. There are also pharmacological measures eg tamoxifen to reduce risk of breast cancer in BRCA1/2 carriers. Then there are clinical trials of preventative interventions eg denosumab in BRCA carriers. |
|
|